JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2007) 192, R1-R8       DOI: 10.1677/JOE-06-0114
© 2007 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chattergoon, N N
Right arrow Articles by Thornburg, K L
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chattergoon, N N
Right arrow Articles by Thornburg, K L

RAPID COMMUNICATION

Thyroid hormone inhibits proliferation of fetal cardiac myocytes in vitro

N N Chattergoon1, G D Giraud1,2,3,4 and K L Thornburg1,2,3

1 Heart Research Center,
2 Departments of Physiology and Pharmacology and
3 Department of Medicine (Cardiovascular Medicine), Oregon Health and Science University, L464, 3181 SW Sam Jackson Park Rd, Portland, Oregon 97239-3098, USA
4 Portland Veterans Affairs Medical Center, Portland, Oregon 97201, USA

(Requests for offprints should be addressed to N N Chattergoon; Email: chatterg{at}ohsu.edu)

Thyroid hormone (T3) is a key regulator of fetal organ maturation. Premature elevations of thyroid hormone may lead to a ‘mature’ cardio-phenotype. Thyroid hormone will stimulate maturation of ovine fetal cardiomyocytes in culture by decreasing their proliferative capacity. Group 1 fetal cardiomyocytes (~135 days gestation) were incubated with T3 (1.5, 3, 10, and 100 nM) and bromodeoxyuridine (BrdU; 10 µM) for 24 and 48 h. Group 2 cardiomyocytes were cultured with T3 alone for later protein analysis of cell cycle regulators. At all concentrations, T3 decreased BrdU uptake fourfold in serum media (P<0.001 versus serum, n = 5). Following serum-free (SF) T3 treatment, BrdU uptake was inhibited when compared with serum (P<0.001 versus serum, n = 5). p21 expression increased threefold (P<0.05 versus serum free, n = 4) and cyclin D1 expression decreased twofold (P<0.05 versus serum, n = 4) in T3-treated cardiomyocytes. (1) T3 inhibits fetal cardiomyocyte proliferation, while (2) p21 protein levels increase, and (3) cyclin D1 levels decrease. Thus, T3 may be a potent regulator of cardiomyocyte proliferation and maturation in the late gestation fetus.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Endocrinology.